个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models (vol 2021, 9911935, 2021)

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Yu Ya-Ya[1,2] * ; Zhu Yan-Juan[1,2,3,4] ; Zou Ying[1,5] ; Xiao Zhen-Zhen[1,2] ; Shi Shuai[1,6] ; Liu Yi-Hong[1,2] ; Chang Xue-Song[1,2] ; Chen Ya-Dong[1,2] ; Zhang Hai-Bo[1,2,3,4,7] ;
机构： [1]Department of Oncology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. [2]Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China. [3]Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou, China. [4]Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China. [5]Department of Integrated Traditional and Western Medicine, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong, China. [6]Department of Respiration Medicine, Luoyang First People's Hospital, Luoyang, Henan, China. [7]State Key Laboratory of Dampness Syndrome of Chinese Medicine, Guangzhou, China.
出处：
DOI： 10.1155/2022/9808974
ISSN：

摘要：
[This corrects the article DOI: 10.1155/2021/9911935.].Copyright © 2022 Ya-Ya Yu et al.

语种：
外文
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2021]版：
大类 | 4 区 医学
小类 | 4 区 全科医学与补充医学
最新[2025]版：
无
JCR分区：
出版当年[2020]版：
Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE
最新[2023]版：
无

影响因子： 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者：
第一作者机构： [1]Department of Oncology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. [2]Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
推荐引用方式(GB/T 7714)：
Yu Ya-Ya,Zhu Yan-Juan,Zou Ying,et al.Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models (vol 2021, 9911935, 2021)[J].Evidence-Based Complementary And Alternative Medicine : Ecam.2022,2022:9808974.doi:10.1155/2022/9808974.
APA：
Yu Ya-Ya,Zhu Yan-Juan,Zou Ying,Xiao Zhen-Zhen,Shi Shuai...&Zhang Hai-Bo.(2022).Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models (vol 2021, 9911935, 2021).Evidence-Based Complementary And Alternative Medicine : Ecam,2022,
MLA：
Yu Ya-Ya,et al."Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models (vol 2021, 9911935, 2021)".Evidence-Based Complementary And Alternative Medicine : Ecam 2022.(2022):9808974

资源点击量：2018 今日访问量：0 总访问量：645 更新日期：2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持：重庆聚合科技有限公司 地址：广州市越秀区大德路111号